These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 34577121)
1. Markov State Models and Molecular Dynamics Simulations Provide Understanding of the Nucleotide-Dependent Dimerization-Based Activation of LRRK2 ROC Domain. Li X; Qi Z; Ni D; Lu S; Chen L; Chen X Molecules; 2021 Sep; 26(18):. PubMed ID: 34577121 [TBL] [Abstract][Full Text] [Related]
2. The Roc-COR tandem domain of leucine-rich repeat kinase 2 forms dimers and exhibits conventional Ras-like GTPase properties. Mills RD; Liang LY; Lio DS; Mok YF; Mulhern TD; Cao G; Griffin M; Kenche VB; Culvenor JG; Cheng HC J Neurochem; 2018 Nov; 147(3):409-428. PubMed ID: 30091236 [TBL] [Abstract][Full Text] [Related]
3. Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity. Nguyen AP; Moore DJ Adv Neurobiol; 2017; 14():71-88. PubMed ID: 28353279 [TBL] [Abstract][Full Text] [Related]
4. Conformational heterogeneity of the Roc domains in C. tepidum Roc-COR and implications for human LRRK2 Parkinson mutations. Rudi K; Ho FY; Gilsbach BK; Pots H; Wittinghofer A; Kortholt A; Klare JP Biosci Rep; 2015 Aug; 35(5):. PubMed ID: 26310572 [TBL] [Abstract][Full Text] [Related]
5. The Parkinson's disease-associated mutation N1437H impairs conformational dynamics in the G domain of LRRK2. Huang X; Wu C; Park Y; Long X; Hoang QQ; Liao J FASEB J; 2019 Apr; 33(4):4814-4823. PubMed ID: 30592623 [TBL] [Abstract][Full Text] [Related]
6. Revisiting the Roco G-protein cycle. Terheyden S; Ho FY; Gilsbach BK; Wittinghofer A; Kortholt A Biochem J; 2015 Jan; 465(1):139-47. PubMed ID: 25317655 [TBL] [Abstract][Full Text] [Related]
7. L'RRK de Triomphe: a solution for LRRK2 GTPase activity? Nixon-Abell J; Berwick DC; Harvey K Biochem Soc Trans; 2016 Dec; 44(6):1625-1634. PubMed ID: 27913671 [TBL] [Abstract][Full Text] [Related]
8. GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2. Biosa A; Trancikova A; Civiero L; Glauser L; Bubacco L; Greggio E; Moore DJ Hum Mol Genet; 2013 Mar; 22(6):1140-56. PubMed ID: 23241358 [TBL] [Abstract][Full Text] [Related]
9. Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant. Daniëls V; Vancraenenbroeck R; Law BM; Greggio E; Lobbestael E; Gao F; De Maeyer M; Cookson MR; Harvey K; Baekelandt V; Taymans JM J Neurochem; 2011 Jan; 116(2):304-15. PubMed ID: 21073465 [TBL] [Abstract][Full Text] [Related]
10. The unconventional G-protein cycle of LRRK2 and Roco proteins. Terheyden S; Nederveen-Schippers LM; Kortholt A Biochem Soc Trans; 2016 Dec; 44(6):1611-1616. PubMed ID: 27913669 [TBL] [Abstract][Full Text] [Related]
11. The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation. Cogo S; Ho FY; Tosoni E; Tomkins JE; Tessari I; Iannotta L; Montine TJ; Manzoni C; Lewis PA; Bubacco L; Chartier Harlin MC; Taymans JM; Kortholt A; Nichols J; Cendron L; Civiero L; Greggio E Brain Res; 2022 Mar; 1778():147781. PubMed ID: 35016853 [TBL] [Abstract][Full Text] [Related]
12. Contribution of GTPase activity to LRRK2-associated Parkinson disease. Tsika E; Moore DJ Small GTPases; 2013; 4(3):164-70. PubMed ID: 24025585 [TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease-associated mutations in the GTPase domain of LRRK2 impair its nucleotide-dependent conformational dynamics. Wu CX; Liao J; Park Y; Reed X; Engel VA; Hoang NC; Takagi Y; Johnson SM; Wang M; Federici M; Nichols RJ; Sanishvili R; Cookson MR; Hoang QQ J Biol Chem; 2019 Apr; 294(15):5907-5913. PubMed ID: 30796162 [TBL] [Abstract][Full Text] [Related]
14. Allosteric modulation of the GTPase activity of a bacterial LRRK2 homolog by conformation-specific Nanobodies. Leemans M; Galicia C; Deyaert E; Daems E; Krause L; Paesmans J; Pardon E; Steyaert J; Kortholt A; Sobott F; Klostermeier D; Versées W Biochem J; 2020 Apr; 477(7):1203-1218. PubMed ID: 32167135 [TBL] [Abstract][Full Text] [Related]
15. First model of dimeric LRRK2: the challenge of unrevealing the structure of a multidomain Parkinson's-associated protein. Guaitoli G; Gilsbach BK; Raimondi F; Gloeckner CJ Biochem Soc Trans; 2016 Dec; 44(6):1635-1641. PubMed ID: 27913672 [TBL] [Abstract][Full Text] [Related]
16. Roco Proteins: GTPases with a Baroque Structure and Mechanism. Wauters L; Versées W; Kortholt A Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609797 [TBL] [Abstract][Full Text] [Related]